Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Vertex Pharmaceuticals (Europe) Ltd
10% owner at CRISPR Therapeutics. Filing since 21 Dec 2018.
CIK 0001761216
Company
Date
Role
Action
Shares
Amount
Of holding
CRSP
CRISPR Therapeutics AG
27 Dec 2018
10% owner
Bought
27,461
$685.12K
0.5%
CRSP
CRISPR Therapeutics AG
26 Dec 2018
10% owner
Bought
12,737
$317.08K
0.2%
CRSP
CRISPR Therapeutics AG
24 Dec 2018
10% owner
Bought
68,000
$1.67M
1.3%
CRSP
CRISPR Therapeutics AG
21 Dec 2018
10% owner
Bought
22,742
$513.48K
0.4%
4 decisions on file.
